Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: SVY

Nanotechnology in Drug Delivery Market to Reach US$ 182.3 Billion by 2027, Globally | CAGR: 19.9% | UnivDatos Market Insights


NOIDA, India, March 8, 2021 /PRNewswire/ -- A comprehensive overview of the Nanotechnology in Drug Delivery market is recently added by UnivDatos Market Insights to its humongous database. The Nanotechnology in Drug Delivery market report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the Nanotechnology in Drug Delivery market. The Nanotechnology in Drug Delivery market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the Nanotechnology in Drug Delivery market at the global and regional level. The Global Nanotechnology in Drug Delivery Market is expected to grow at a CAGR of 19.9% from 2021-2027 to reach USD 182.3 billion by 2027.

UnivDatos_Logo

Market Overview

The Global Nanotechnology in Drug Delivery Market is experiencing significant growth on account of surging prevalence of cancer and other diseases. More people die from CVDs worldwide than from any other source, according to the World Health Organization with over 17.9 million per year. In 2020, American Heart Association has set a goal of reducing cardiovascular disease and stroke deaths by 20% and thus focused on enhancing factors such as physical activity, diet, obesity/overweight, smoking, blood pressure, cholesterol, and blood sugar. The rising number of deaths cause increased burden among the people, which can surge the demand for novel nanotechnology drug delivery techniques that are efficient than traditional medicine and therefore is expected to drive the general market to grow.

There has been major expansion in the transformation of nano-based cancer therapies and diagnostics and different new technologies are in the pipeline. Nanomedicine and nano delivery systems are being utilized as diagnostic tools or in delivering therapeutic agents to specific targeted sites in a controlled manner wherein materials are used in the nanoscale range. Since 1995, nearly 50 nano pharmaceuticals have received FDA approval and are currently available for clinical use. In oncology, over 20% of the therapeutic nanoparticles already in clinics or under clinical evaluation have been created. Most FDA-approved therapeutic nanoparticles are currently being designed for the re-formulation of combinations of chemotherapeutic drugs with polymeric nanoparticles.

Request Sample Copy of this Report @ https://univdatos.com/report/global-nanotechnology-in-drug-delivery-market-current-analysis-and-forecast-2020-2027

COVID-19 Impact

The current impact of COVID-19 on global health is enormous, but in addition, the worldwide impact on the economy, employees, and companies is going to be considerable. This global emergency calls for a science and technology response to the COVID-19 pandemic, where advanced solutions during the epidemic are anticipated to be explored by nanotechnology. A study performed by Leuschner et al. brings a direction in the use of nanotechnology to control the cytokine storm which is amongst few clinical complications of COVID-19. Nanoparticles perform an essential role at different stages of disease pathogenesis, contemplating their inhibition potential in the initial attachment and membrane fusion during viral entry and infected cell protein fusion.

Ask for Price & Discounts @ https://univdatos.com/report/global-nanotechnology-in-drug-delivery-market-current-analysis-and-forecast-2020-2027 

Global Nanotechnology in Drug Delivery Market report is studied thoroughly with several aspects that would help stakeholders in making their decisions more curated.

By Technology, the market is primarily bifurcated into

Nanoparticles segment dominated the by type of the global nanotechnology in drug delivery market and will row at 19.4% CAGR to reach US$ 48.1 billion by the year 2027.

By Application, the market is primarily segmented into

Amongst application type, oncology accounted for the largest share and is expected to grow at 20% CAGR during the forecast period 2021-2027. In 2019, the oncology segment accounted for a revenue share of almost 36%.

Nanotechnology in Drug Delivery Market Geographical Segmentation Includes:

Based on the estimation, the North America region dominated the Nanotechnology in Drug Delivery market with almost US$ 18.9 billion revenue in 2019. At the same time, the Asia-Pacific region is expected to grow remarkably with a CAGR of 22.5% over the forecast period on account of the increasing population and modernization of healthcare infrastructure.

Ask for Report Customization @ https://univdatos.com/report/global-nanotechnology-in-drug-delivery-market-current-analysis-and-forecast-2020-2027

The major players targeting the market includes

Competitive Landscape

The degree of competition among prominent global companies has been elaborated by analyzing several leading key players operating worldwide. The specialist team of research analysts sheds light on various traits such as global market competition, market share, most recent industry advancements, innovative product launches, partnerships, mergers, or acquisitions by leading companies in the nanotechnology in drug delivery market. The leading players have been analyzed by using research methodologies for getting insight views on global competition.

Key questions resolved through this analytical market research report include:

We understand the requirement of different businesses, regions, and countries, we offer customized reports as per your requirements of business nature and geography. Please let us know If you have any custom needs.

For more informative information, please visit us @ https://univdatos.com/report/global-nanotechnology-in-drug-delivery-market-current-analysis-and-forecast-2020-2027

About UnivDatos Market Insights

UnivDatos Market Insights (UMI) is a passionate market research firm and a subsidiary of Universal Data Solutions. We believe in delivering insights through Market Intelligence Reports, Customized Business Research, and Primary Research. Our research studies are spread across topics across the world, we cover markets in over 100 countries using smart research techniques and agile methodologies. We offer in-depth studies, detailed analysis, and customized reports that help shape winning business strategies for our clients.

Contact

UnivDatos Market Insights
Pawnendra Pawan
Client Development Lead
Ph: +91-7838604911
Email: [email protected]
Website: https://univdatos.com/

Logo: https://mma.prnewswire.com/media/1225049/UnivDatos_Logo.jpg


These press releases may also interest you

at 08:40
The "United States Self-Monitoring Blood Glucose Devices Market Growth, Share, Size, Trends, Analysis and Forecast (2024 - 2032)" report has been added to ResearchAndMarkets.com's offering. The U.S. Self-Monitoring Blood Glucose Devices market size...

at 08:35
Arch Insurance North America (Arch), a provider of specialized insurance and risk management solutions, today unveiled its latest products available through the Arch APEX? digital platform. Participant Accident coverage is now available for child...

at 08:35
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Vemlidy® (tenofovir alafenamide) 25 mg tablets as a once-daily treatment for chronic hepatitis B...

at 08:35
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported financial...

at 08:30
Solitario Resources Corp. ("Solitario") is pleased to report that it has discovered another high-grade gold zone on its Golden Crest project, named Sleeping Beauty. Recently received assay results from reconnaissance rock sampling of...

at 08:30
Camber Energy, Inc. ("Camber" or the "Company"), today announced that on March 26, 2024, the U.S. Patent and Trademark Office (USPTO) issued U.S. patent11,942,776 entitled "Electric Transmission Line Ground Fault Prevention...



News published on and distributed by: